Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia
View ORCID ProfileCecile P. G. Meier-Scherling, View ORCID ProfileOliver J Watson, Victor Asua, Isaac Ghinai, Thomas Katairo, Shreeya Garg, View ORCID ProfileMelissa Conrad, View ORCID ProfilePhilip J. Rosenthal, Lucy C Okell, Jeffrey A. Bailey
doi: https://doi.org/10.1101/2024.02.03.24302209
Cecile P. G. Meier-Scherling
1Center for Computational Molecular Biology, Brown University, Providence, RI, USA
BScOliver J Watson
2Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK
Ph.DVictor Asua
3Infectious Diseases Research Collaboration, Kampala, Uganda
MScIsaac Ghinai
4Oxford University, Oxford, UK
MScThomas Katairo
3Infectious Diseases Research Collaboration, Kampala, Uganda
Ph.DShreeya Garg
5Department of Medicine, University of California San Francisco, San Francisco, CA, USA
BScMelissa Conrad
5Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Ph.DPhilip J. Rosenthal
5Department of Medicine, University of California San Francisco, San Francisco, CA, USA
MD/Ph.DLucy C Okell
2Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK
Ph.DJeffrey A. Bailey
1Center for Computational Molecular Biology, Brown University, Providence, RI, USA
6Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, RI, USA
MD/Ph.D
Data Availability
All data produced are available online at https://github.com/bailey-lab/selmar.
Posted February 04, 2024.
Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia
Cecile P. G. Meier-Scherling, Oliver J Watson, Victor Asua, Isaac Ghinai, Thomas Katairo, Shreeya Garg, Melissa Conrad, Philip J. Rosenthal, Lucy C Okell, Jeffrey A. Bailey
medRxiv 2024.02.03.24302209; doi: https://doi.org/10.1101/2024.02.03.24302209
Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia
Cecile P. G. Meier-Scherling, Oliver J Watson, Victor Asua, Isaac Ghinai, Thomas Katairo, Shreeya Garg, Melissa Conrad, Philip J. Rosenthal, Lucy C Okell, Jeffrey A. Bailey
medRxiv 2024.02.03.24302209; doi: https://doi.org/10.1101/2024.02.03.24302209
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)